Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: San Francisco CA
Sponsor: Robert Bok, MD, PhD

Sex: All

Age: 18+

Code: NCT05599048

Phase 1, Phase 2, Recruiting

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

for
Breast Cancer, Prostate Cancer
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT07014618

Recruiting

A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, ICI-refractory
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07133425

Phase 2, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Westbrook ME, Burlington MA, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase 3, Recruiting

A Five-Year Quality of Life Study for Cancer Patients

for
Cancer
Location: Grapevine TX
Sponsor: Constantine A. Kotsanis

Sex: All

Age: 18+

Code: NCT01539148

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

for
Metastatic Breast Cancer, Lobular Breast Carcinoma
Location: Philadelphia PA, Houston TX, San Diego CA,
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05964504

Recruiting

Saci Nivo Rela for TNBC

for
Metastatic Triple-negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06963905

Phase 1, Phase 2, Recruiting

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

for
Neoplasms, Cancer, Caregiver
Location: Washington D.C. DC
Sponsor: Cancer Support Community, Research and Training Institute, Philadelphia

Sex: All

Age: 18+

Code: NCT02333604

Recruiting

Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit

for
Depression, Cancer, Adolescent, Young Adult, Adult
Location: Greenville NC, Winston-Salem NC
Sponsor: East Carolina University

Sex: All

Age: 15 - 39

Code: NCT07173205

Recruiting

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

for
Breast Cancer
Location: New York NY, Montvale NJ
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT05130801

Phase 1, Phase 2, Recruiting

[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy

for
Cancer
Location: San Francisco CA
Sponsor: CellSight Technologies, Inc.

Sex: All

Age: 18 - 65

Code: NCT03142204

Phase 1, Recruiting

Comprehensive Connected Cancer Care (C4): Intervention Evaluation

for
Cancer, Health Care Utilization
Location: Lexington KY
Sponsor: Timothy Mullett

Sex: All

Age: 18+

Code: NCT06326567

Recruiting

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

for
Breast Cancer, Breast Carcinoma, Cancer of the Breast,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07067138

Recruiting

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07191717

Phase 2, Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase 3, Recruiting

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

for
Adjustment Disorder, Anxiety Disorder, Depression,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT07221409

Recruiting

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

for
Breast Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT07220967

Recruiting

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

for
Breast Cancer
Location: Voorhees Township NJ, Jacksonville FL, Houston TX,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07076485

Phase 2, Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

for
Metastatic Solid Tumor, Advanced Solid Tumor
Location: Lake Success NY, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06657144

Phase 1, Recruiting

Synapse 3D With Intravascular Indocyanine Green

for
Non-small Cell Lung Cancer, Primary Neoplasm
Location: Hamilton
Sponsor: St. Joseph's Healthcare Hamilton

Sex: All

Age: 18+

Code: NCT03953144

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial